Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  HISTORICAL VOLUME
Historical Volume      
Senores Pharmaceuticals Ltd.
BSE Code 544319
ISIN Demat INE0RB801010
Book Value 155.63
NSE Code SENORES
Dividend Yield % 0.00
Market Cap 35585.61
P/E 258.05
EPS 2.99
Face Value 10  
Exchange : Period From : Period To :
DateOpen Price(Rs.)High Price(Rs.)Low Price(Rs.)Close Price(Rs.)VolumeTurnover
26-Feb-2026 781.75 789.70 765.00 772.70 4936 3839712
25-Feb-2026 782.30 790.40 769.30 770.75 4882 3800842
24-Feb-2026 795.00 795.00 775.00 780.40 3350 2626756
23-Feb-2026 824.90 824.90 790.50 793.35 2813 2248112
20-Feb-2026 810.45 819.00 805.40 810.20 2895 2349719
19-Feb-2026 829.75 846.95 810.05 815.10 4925 4103736
18-Feb-2026 801.35 838.00 800.30 821.60 11061 9140958
17-Feb-2026 792.00 804.70 788.80 796.00 3342 2662321
16-Feb-2026 785.25 806.00 767.90 792.80 14633 11575963
13-Feb-2026 793.05 799.95 781.00 785.25 3756 2960444
12-Feb-2026 818.70 822.95 800.20 802.75 8822 7140849
11-Feb-2026 838.95 838.95 806.80 818.30 3513 2868072
10-Feb-2026 839.20 846.95 824.95 829.30 3401 2842516
09-Feb-2026 830.00 848.10 824.70 834.00 6979 5836707
06-Feb-2026 826.00 836.80 813.80 824.95 4613 3808318
05-Feb-2026 819.60 827.35 813.80 822.05 2964 2432299
04-Feb-2026 814.00 827.40 813.00 820.05 2980 2444272
03-Feb-2026 817.95 827.50 805.90 812.90 10099 8245805
02-Feb-2026 814.90 814.90 772.30 781.50 3108 2424900
01-Feb-2026 791.25 795.20 774.85 787.40 5584 4392981
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.